Surgery Today

, Volume 26, Issue 3, pp 213–216 | Cite as

Cervical Castleman's disease associated with benign M-proteinemia: Report of a case

  • Makoto Komatsu
  • Takashi Ehara
  • Takai Kuroda
Case Reports


We report the unusual case of a 77-year-old man with cervical Castleman's disease associated with benign M-proteinemia. The patient was found to have an anterior cervical tumor during a follow-up examination after surgery for early gastric cancer, at which time blood biochemistry tests revealed M-proteinemia at the position of β-globulin with a high level of IgG and low levels of IgA and IgM. Serum protein immunoelectrophoresis revealed M-protein consisting of the IgG-k chain, and urine protein immunoelectrophoresis demonstrated Bence Jones protein consisting of the chain. No abnormalities were noted in bone marrow aspiration or bone scintigram. The results of imaging and fine-needle aspiration biopsy of the tumor led to a preoperative diagnosis of cervical malignant lymphoma with suspected M-proteinemia derived from this disease, and resection of the anterior cervical tumor with bilateral neck dissection was performed. Histopathological examination subsequently demonstrated four mixed-type tumors of Castleman's disease. The pathogenesis of Castleman's disease remains unknown; however, we speculate that the complication of benign M-proteinemia in this patient was not incidental, but caused by an underlying immunological abnormality of the B cells.

Key Words

Castleman's disease benign M-proteinemia immunological abnormality of the B cells 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Castleman B, Inverson L, Menendez VP (1956) Localized mediastinal lymph-node hyperplasia resembling thymoma. Cancer 9:822–830Google Scholar
  2. 2.
    Keller AR, Hochholzer L, Castleman B (1972) Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 29:670–683Google Scholar
  3. 3.
    Gaba AR, Stein RS, Sweet DL, Variakojis D (1978) Multicentric giant lymph node hyperplasia. Am J Clin Pathol 69:86–90Google Scholar
  4. 4.
    Fizzera G, Peterson BA, Bayrd ED, Goldman A (1985) A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: Clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 3:1202–1216Google Scholar
  5. 5.
    Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K, Nakahata T, Kawai H, Tagoh H, Komori T, Kishimoto S, Hirano T, Kishimoto T (1989) Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 74:1360–1367Google Scholar
  6. 6.
    Beck JT, Hsu S-M, Wijdens J, Bataille R, Klein B, Vesole D, Hayden K, Jagannath S, Barlogie B (1994) Alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N Engl J Med 330:602–605Google Scholar
  7. 7.
    Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto A, Kishimoto T (1988) Autocrine generation and requirement of BSF/IL-6 for human multiple myeloma. Nature 332:83–85Google Scholar
  8. 8.
    Nakanishi T, Sobue I, Toyokura Y, Nishitani H, Kuroiwa Y, Satoyoshi E, Tsubaki T, Igata A, Ozaki Y (1984) The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology 34:712–720Google Scholar
  9. 9.
    Mandler RN, Kerrigan DP, Smart J, Kuis W, Villinger P, Lotz M (1992) Castleman's disease in POEMS syndrome with elevated inter-leukin-6. Cancer 69:2697–2703Google Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • Makoto Komatsu
    • 1
  • Takashi Ehara
    • 2
  • Takai Kuroda
    • 3
  1. 1.Department of SurgeryFujimi-kogen HospitalSuwaJapan
  2. 2.Department of PathologyShinshu University School of MedicineMatsumotoJapan
  3. 3.Department of SurgeryShinshu University School of MedicineMatsumotoJapan

Personalised recommendations